Cytek Biosciences Inc (CTKB)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Total Revenue | 40.48M | 48.34M | 37.09M | 49.69M | 48M | 58.23M | 44.86M | 46.62M |
Operating Income | 1.36M | -146k | -12.16M | -9.13M | -6.42M | -1.64M | -10.73M | -8.53M |
Pre Tax Income | 1.85M | 4.11M | -9.04M | -6.6M | -4.19M | 4.11M | -8.99M | -7.19M |
Net Income | 1.67M | 3.53M | -6.81M | -4.39M | -6.46M | 5.5M | -6.17M | -10.43M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 915k | 872k | -10.51M | -7.39M | -5.21M | 1.56M | -9.91M | -8.47M |
EBITDA | 1.43M | 615k | -11.16M | -7.48M | -4.65M | -6k | -9.04M | -6.72M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 92.84M | 127.95M | 164.04M | 193.02M |
Operating Income | 13.66M | 9.16M | -1.8M | -27.85M |
Pre Tax Income | 14.43M | 5.94M | 1.26M | -15.71M |
Net Income | 3.22M | 0 | 2.58M | -12.15M |
Preferred Dividends | -16.2M | -3M | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.137 | 0 | 0.019 | -0.09 |
EBIT | 14.65M | 7.63M | -786k | -20.05M |
EBITDA | 14.26M | 10.4M | 688k | -21.8M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.